ADMA Biologics Inc

ADMA Biologics Insider Surge: CEO Buys, CFO & COO Sell Amid 885k‑Dollar RSU Grant—Short‑Term Volatility vs. Long‑Term Commitment【Financial Times】

ADMA Biologics insider moves: CFO’s RSU grant valued over $885K, CEO’s buy‑sell strategy, and COO’s sales—all impact short‑term volatility and long‑term commitment.

ADMA Biologics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

27/02/2026, 03:16

3 minutes to read

ADMA Biologics COO Ramps Up Holdings: Insider Buys 91,631 Shares, Signaling Confidence Amid Market Volatility

ADMA Biologics insider buying: COO Kaitlin Kestenberg‑Messina adds 91k shares, signaling management confidence amid market volatility and pipeline growth.

ADMA Biologics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

12/02/2026, 03:16

4 minutes to read